Prescription for a Healthy Canadian Biopharma Industry

1
(No Transcript)
2
Building Value in Corporations

• CFO Track

John Lawson Pierre Bourassa
3
Traditional Drug Development process
4
Risk vs. valuation correlation
Source MDS
5
What does Big Pharma seek?
Bourassa Lawson 2007
6
Key Success Factors for SMEs
Bourassa Lawson 2007
7
Todays panelists

• Bertrand Bolduc, President CEO Mistral Pharma
• Adam Buckley, VP Variation Biotech
• Jean Paul Castaigne, CEO Angiochem
• Monique Letourneau, CFO Ambrilia

8
(No Transcript)